Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fibrinogen linked to dangerous low density lipoprotein (LDL)

This article was originally published in Clinica

Executive Summary

Fibrinogen is not just a marker for the risk of blood clotting, it is also linked to high levels of particularly dangerous forms of LDL and low HDL, say German researchers. Writing in the January issue of Arteriosclerosis, Thrombosis and Vascular Biology, Dr Martin Halle of the Freiburg Medical Clinic says individuals with elevated levels of fibrinogen should be advised to stay lean and fit and avoid saturated fatty acids.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT087035

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel